SelectQuote (SLQT) said Friday it "firmly rejects" allegations made in a US Department of Justice complaint that was filed last week against various participants in the Medicare Advantage industry.
The company said it believes the allegations are incorrect as they misrepresent the overall industry and its business model.
SelectQuote said it has been cooperating with the DOJ since 2022 as previously disclosed and that it will defend itself against the allegations.
Shares of SelectQuote were up about 2.5% in recent pre-market activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.